topicResveratrol Cognition Randomized Trial
claimObservational associations between dietary patterns and reduced dementia risk have prompted investigations of dietary bioactives (DBs) as cognitive nutraceuticals.
evidence level2
citationKumari A (2026)
sourceDietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies.
topicResveratrol Cognition Randomized Trial
claimFindings are synthesized qualitatively; no formal meta-analysis or risk of bias assessment was conducted.
evidence level2
citationKumari A (2026)
sourceDietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies.
topicResveratrol Cognition Randomized Trial
claimCannabinoids improved behavioral symptoms but showed no measurable cognitive effects.
evidence level2
citationKumari A (2026)
sourceDietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies.
topicResveratrol Cognition Randomized Trial
claimMethods: This critical narrative review examines interventional trials for nine prominent DBs relevant to AD: docosahexaenoic acid (DHA), curcumin, resveratrol, epigallocatechin gallate (EGCG), nicotinamide riboside (NR), tricaprilin, vitamin E (α-tocopherol), cannabinoids, and NIC5-15 (D-pinitol).
evidence level2
citationKumari A (2026)
sourceDietary Bioactives in Alzheimer's Disease: A Critical Appraisal of Clinical Trials and Future Nutritional Strategies.
topicResveratrol Cognition Randomized Trial
claimDietary patterns have emerged as modifiable risk factors that may influence disease onset and progression.
evidence level4
citationFekete M (2025)
sourceMediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein.
topicResveratrol Cognition Randomized Trial
claimThe Mediterranean diet (MedDiet), rich in fruits, vegetables, whole grains, legumes, fish, and extra virgin olive oil, has been consistently associated with better cognitive outcomes and reduced risk of neurodegeneration.
evidence level4
citationFekete M (2025)
sourceMediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein.
topicResveratrol Cognition Randomized Trial
claimAim: This narrative review summarizes current evidence on the role of the MedDiet in slowing the progression of neurodegenerative diseases, with a particular focus on polyphenols such as resveratrol and oleuropein as key bioactive mediators.
evidence level4
citationFekete M (2025)
sourceMediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein.
topicResveratrol Cognition Randomized Trial
claimBackground: Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are among the leading causes of disability and mortality worldwide.
evidence level4
citationFekete M (2025)
sourceMediterranean Diet, Polyphenols, and Neuroprotection: Mechanistic Insights into Resveratrol and Oleuropein.